EarningsSILVAPHL
SILVAPHL Earnings Update — FY 2021–22
Announcement summary
- What happened
- SILVAPHL published a corporate disclosure on 30 October 2022. Read the full announcement for details.
- Company
- Silva Pharmaceuticals Limited
- Announcement published
Original announcement
(Continuation news of SILVAPHL): Venue: Digital Platform, Record Date: 01.12.2022. The Company has reported EPS of Tk. 0.75, NAV per share of Tk. 17.03 and NOCFPS of Tk. 1.18 for the year ended June 30, 2022 as against Tk. 0.88, Tk. 16.63 and Tk. 1.17 respectively for the same period of the previous year. Reason for deviation in EPS: EPS has decreased as revenue has been decreased and the cost of goods sold have been increased due to raw material price increased in local and international market. (end)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 635debbfb2c25841940abd8d
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILVAPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.